Nexpring Health

Nexpring Health is a global medtech company focused on Assisted Reproductive Technology (ART). Formed through the combination of leading reproductive health businesses, it is headquartered in the USA and serves over 3,000 fertility clinics and IVF laboratories across more than 115 countries. The company employs around 650 people. Nexpring Health offers a comprehensive portfolio of ART solutions, including consumables and equipment essential for in-vitro fertilization (IVF) procedures. The company integrates expertise from established brands to create a unified ecosystem of innovative solutions that simplify complex fertility treatments and improve patient outcomes. Its services enhance laboratory and clinic workflows, providing specialized support and ensuring operational continuity. The company collaborates closely with fertility professionals to understand their challenges and develop solutions that optimize clinical results. Its customers include fertility clinics, IVF laboratories, hospitals, embryologists, and reproductive medicine practitioners, reflecting its commitment to supporting the professionals in fertility care. Nexpring Health aims to remove complexity in ART and deliver consistent outcomes in every procedure and cycle.

• Employees 300